Healthcare provider profile · identity verified

Rachel Singer, CNP

Nurse Practitioner · CANTON, OH · NPI 1093073546

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	546	126
Furosemide	Furosemide	375	89
Lisinopril	Lisinopril	307	66
Potassium Chloride	Potassium Chloride	300	60
Amlodipine Besylate	Amlodipine Besylate	298	67
Gabapentin	Gabapentin	290	57
Levothyroxine Sodium	Levothyroxine Sodium	267	61
Albuterol Sulfate Hfa	Albuterol Sulfate	264	72
Metformin Hcl	Metformin Hcl	252	44
Losartan Potassium	Losartan Potassium	249	42
Pantoprazole Sodium	Pantoprazole Sodium	225	62
Omeprazole	Omeprazole	224	46
Metoprolol Succinate	Metoprolol Succinate	203	49
Trazodone Hcl	Trazodone Hcl	177	43
Sertraline Hcl	Sertraline Hcl	175	48
Eliquis	Apixaban	164	43
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	157	38
Carvedilol	Carvedilol	148	25
Prednisone	Prednisone	142	78
Metoprolol Tartrate	Metoprolol Tartrate	137	24
Tramadol Hcl	Tramadol Hcl	136	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	121	27
Tizanidine Hcl	Tizanidine Hcl	121	25
Buspirone Hcl	Buspirone Hcl	116	29
Hydroxyzine Hcl	Hydroxyzine Hcl	111	27
Montelukast Sodium	Montelukast Sodium	108	21
Escitalopram Oxalate	Escitalopram Oxalate	106	27
Hydrochlorothiazide	Hydrochlorothiazide	102	16
Jardiance	Empagliflozin	101	16
Fenofibrate	Fenofibrate Nanocrystallized	100	13
Fluticasone Propionate	Fluticasone Propionate	99	23
Tamsulosin Hcl	Tamsulosin Hcl	97	25
Clopidogrel	Clopidogrel Bisulfate	94	23
Mirtazapine	Mirtazapine	93	23
Pravastatin Sodium	Pravastatin Sodium	92	21
Meloxicam	Meloxicam	90	18
Duloxetine Hcl	Duloxetine Hcl	88	24
Ondansetron Hcl	Ondansetron Hcl	88	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	15
Allopurinol	Allopurinol	81	21
Diclofenac Sodium	Diclofenac Sodium	81	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	27
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	77	56
Myrbetriq	Mirabegron	76	suppressed
Levetiracetam	Levetiracetam	72	12
Spironolactone	Spironolactone	68	17
Famotidine	Famotidine	67	21
Trulicity	Dulaglutide	67	12
Pregabalin	Pregabalin	65	suppressed
Alendronate Sodium	Alendronate Sodium	64	suppressed
Xarelto	Rivaroxaban	64	12
Fluoxetine Hcl	Fluoxetine Hcl	63	14
Oxybutynin Chloride Er	Oxybutynin Chloride	62	21
Metformin Hcl Er	Metformin Hcl	61	14
Ozempic	Semaglutide	60	13
Rosuvastatin Calcium	Rosuvastatin Calcium	58	15
Topiramate	Topiramate	50	suppressed
Fluconazole	Fluconazole	49	23
Hydralazine Hcl	Hydralazine Hcl	49	13
Simvastatin	Simvastatin	49	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	39
Citalopram Hbr	Citalopram Hydrobromide	46	12
Mounjaro	Tirzepatide	46	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	44	11
Memantine Hcl	Memantine Hcl	44	suppressed
Nystatin	Nystatin	44	21
Baclofen	Baclofen	42	suppressed
Celecoxib	Celecoxib	42	16
Doxycycline Hyclate	Doxycycline Hyclate	41	36
Lactulose	Lactulose	41	16
Lidocaine	Lidocaine	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Torsemide	Torsemide	39	12
Bupropion Xl	Bupropion Hcl	37	suppressed
Glimepiride	Glimepiride	37	suppressed
Azithromycin	Azithromycin	36	31
Donepezil Hcl	Donepezil Hcl	35	suppressed
Promethazine Hcl	Promethazine Hcl	35	suppressed
Spiriva Handihaler	Tiotropium Bromide	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	13
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Lorazepam	Lorazepam	30	11
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Bumetanide	Bumetanide	29	suppressed
Naproxen	Naproxen	29	13
Sucralfate	Sucralfate	29	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Linzess	Linaclotide	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	23
Dulera	Mometasone/Formoterol	26	suppressed
Glipizide	Glipizide	26	suppressed
Levofloxacin	Levofloxacin	26	19
Cephalexin	Cephalexin	25	suppressed
Diazepam	Diazepam	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Finasteride	Finasteride	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Tresiba Flextouch U-200	Insulin Degludec	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Mupirocin	Mupirocin	20	suppressed
Nystop	Nystatin	20	14
Roflumilast	Roflumilast	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Risperidone	Risperidone	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Carbamazepine Er	Carbamazepine	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Nyamyc	Nystatin	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Tiotropium Bromide	Tiotropium Bromide	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Atenolol	Atenolol	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Klor-Con 10	Potassium Chloride	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Leflunomide	Leflunomide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error